Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kadry Elsaeed"'
Autor:
Mohammad El-Sayed, Magdy Elserafy, Maissa El Raziky, Wafaa Elakel, Yasmin Saad, Tarek Fayad, Mohamed Korany, Mai Mehrez, Rabab Salama, Maged Mahrous, Ayman Zaki, Mohamed Hassany, Islam Ammar, Kadry Elsaeed, Yehia Elshazly, Wahid Doss
Publikováno v:
Arab Journal of Gastroenterology. 24:29-33
Publikováno v:
QJM: An International Journal of Medicine. 114
Background The introduction of direct-acting antiviral agents, has revolutionized the treatment for chronic HCV with higher cure rates, shorter duration of treatment and more tolerability have been achieved. Objectives The aim of our study is to esti
Publikováno v:
Egyptian Liver Journal, Vol 11, Iss 1, Pp 1-5 (2021)
BackgroundCure of chronic hepatitis C (HCV) in HIV/HCV co-infected patients is a priority due to their increased risk of complications. Daclatasvir and sofosbuvir treatment regimens with or without ribavirin are considered an important chance for bet
Autor:
Mohammed Abd Algaber, Heba Omar, Yasmeen Abd El Latif, Mohamed El Kassas, Kadry Elsaeed, Magdy El-Serafy, Wahid Doss, Hesham El Halwagy, Shimaa Afify, Adel El Tahan, Mohamed Alboraie
Publikováno v:
Journal of Medical Virology. 94:667-674
INTRODUCTION AND AIMS Treatment of hepatitis C virus (HCV) genotype 4 patient with fixed dose combination of ombitasvir-paritaprevir-ritonavir plus ribavirin (OBV/rPTV/RBV) has been proven efficacy and safety in many clinical trials. The current stud
Publikováno v:
F1000Research. 11:649
Background: Treatment of chronic hepatitis C (CHC) with direct acting antivirals (DAAS) improves the rates of sustained virological response (SVR). However, derangements with lipid profile and glycemic status have been observed. This study aimed to c
Autor:
Tamer Elbaz, A. Nasr, Mohamed AbdAllah, Wahid Doss, W. El Akel, Y. El Shazly, Mohammed Shaker, Ahmed A. Gomaa, Imam Waked, Mohd Shahrir Mohamed Said, Sohier Ahmed Ismail, Gamal Esmat, H. El Shazly, M. El Kassas, Mohamed Korany, Kadry Elsaeed, Heba Omar, Monkez M Yousif
Publikováno v:
Alimentary Pharmacology & Therapeutics. 47:421-431
SummaryBackground Treatment of chronic hepatitis C using combination of sofosbuvir (SOF) and daclatasvir (DCV) was used in several clinical trials and multicentre studies, which were somewhat limited to genotypes 1-3. The national program in Egypt is
Autor:
Yehia El Shazly, Ahmed A. Gomaa, Wafaa El-Akel, Mai Mehrez, Mohamed Abdullah, Mahamed El Kassas, Heba Omar, Maissa El Raziky, Imam Waked, Samar K Darweesh, Wahid Doss, Gamal Esmat, Kadry Elsaeed, Mohammed Shaker, Magdy El-Serafy, Sohier Ahmed Ismail
Publikováno v:
Expert review of gastroenterologyhepatology. 13(9)
Aim: Evaluation of the efficacy and safety of sofosbuvir/daclatasvir/ribavirin (SOF/DCV/RBV) in treating non-sustained virological responders (non-SVR12) to prior sofosbuvir-based therapy, in absence of RAS testing in mass treatment, and determinatio
Autor:
Mohamed Alboraie, Walied Elhossary, Osama Aboelfotoh Aly, Bahaa Abbas, Lobna Abdelsalam, Doaa Ghaith, Zakarya Shady, Yasmine Gaber, Eman Adel, David Peura, David Armstrong, Gamal Esmat, Ahmed Gomaa, Ahmed El Ray, Ahmed Altonbary, Ahmad Soliman, Ahmed Zeid, Amgad Elzahaby, Assem Elfert, Hany Shehab, Ibrahim Mostafa, Kadry Elsaeed, Magdy El-Serfay, Maged El-Ghannam, Mahmoud El Ansary, Mohamed Metwally, Mohamed Emara, Muhammad Abdel Ghaffar, Samy Zaky, Sherief Abd-Elsalam
Publikováno v:
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology. 20(3)
Autor:
Mohamed El Kassas, Mohamed Salaheldin, Mohamed El Badry, Yasmeen Mahmoud Ahmed, Talaat Fathy, Ibrahim Kabbash, Yehia ElShazly, Kadry Elsaeed, Mohamed Alboraie, Omkolsoum M Alhaddad, Adel El Tahan, Wahid Doss, Magdy El-Serafy, Gamal Esmat
Publikováno v:
American journal of therapeutics. 25(6)
Autor:
Wahid Doss, Heba Omar, Enass Moaz, Gamal Esmat, Mohamed El Kassas, Mahmoud Abouelkhair, Dalia Omran, Mohamed Elbadry, Shimaa Afify, Mohamed Alboraie, Kadry Elsaeed, A.M. Farid, Adel El Tahan, Mohamed-Naguib Wifi, Mohamed Salaheldin, Yehia El Shazly, Sameera Ezzat
Publikováno v:
Expert review of gastroenterologyhepatology. 12(12)
A large Egyptian treatment program for HCV was launched in2014 after the introduction of direct-acting antiviral agents (DAAs). This program depended mainly on establishing specialized independent centres for HCV treatment. These centres represent th